综合评估血栓与出血风险,审慎抉择抗栓治疗方案

Cautiously Making Antithrombotic Therapy Decision-making after Evaluating Thrombotic and Bleeding Risk

抗栓治疗是血栓性疾病防治的重要手段,出血是影响抗栓治疗效果、甚至危及生命的最常见的并发症之一。正确评估减少缺血性事件与出血并发症之间的利弊,个体化制定抗栓治疗方案,是临床面临的重大挑战。老年人、多种抗栓药物联用、有创检查或围术期血栓与出血风险均高等情况下,需综合评估临床状况,谨慎选择抗栓治疗方案。

Antithrombotic therapy is a key method to prevent or cure thromboemholic disease. Bleeding, as one of its most common complications, affects antithromhotic treatment effects, or even threats the patients＇ life. How to identify the right balance between benefits in reducing ischemic events and increased risk of bleeding complications, make antithrombotic strategy individually is a big challenge in clinical settings. More cautiousness should be paid on making antithrombotic therapy decision after systemic assessment, especially in the eldly, combination use of antithrombotic agents, peri-operation or peri-- invasive procedures or in high thrombotic and hemorrhage risk status, etc.